COMP <GO>
ANIP vs JNJ // 10Y YIELD & FRED MACRO BETA
ANI Pharmaceuticals Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: ANIP 5
— JNJ 6
■ METRIC PARITY
LAST: $73.16 (+2.02%) • MKT CAP: $1.68B
macro-sensitivity
—
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
macro-sensitivity
1.08
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ANIP VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ANIP | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 67.90% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.00% | 25.50% | -9.50 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.7x | 18.5x | -4.80 | ANIP | /valuation <GO> |
| Free Cash Flow Yield | 10.20% | 2.97% | +7.23 | ANIP | /fcf-yield <GO> |
| Operating Margin | 12.60% | 34.70% | -22.10 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 8.80% | 28.50% | -19.70 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 43.80% | 6.00% | +37.80 | ANIP | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.07% | 0.00% | +0.07 | ANIP | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.36 | 5.59 | -3.23 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.7 | 62.1 | -10.40 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.1x | 23.0x | -4.90 | ANIP | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.68B | $662.49B | -$660.81B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ANIP REV | JNJ REV | ANIP GROSS % | JNJ GROSS % | ANIP FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $883.4M | $94.19B | — | 67.9% | $171.4M | $19.70B |
| FY 2024 | $614.4M | $88.82B | — | 69.1% | $47.8M | $19.84B |
| FY 2023 | $486.8M | $85.16B | — | — | $119.0M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ANIP // BETA —
JNJ // BETA 1.08